ENEhsan Nozohouri

Ehsan Nozohouri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ehsan Nozohouri has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Multivariable Design of a Minimalist Conjugated Polymer Nanoparticle with Bright NIR‐II Emission

    by Nikita Gill, Robert Posey, Brenda Alfaro, Helena Garza, Jacquelyn Tran, Kazi Mustafa Mahmud, Annemarie C. Fritz, Tahamida Alam Oyshi, Ehsan Nozohouri, Indrajit Srivastava, et al.

    Near‐infrared (NIR) emitting materials underpin emerging medical diagnostics and therapeutic bionanotechnologies. In particular, the NIR‐II window (1000–1700 nm) allows for enhanced penetration depth and image clarity in vivo by minimizing light‐tissue interactions. Organic materials are advantageous due to their synthetic tunability; however, the energy gap law poses fundamental limitations on accessible quantum yields (Φ) due to the exponential increase in nonradiative decay rates as the bandgap narrows. Conjugated polymer nanoparticles (CPNs) offer biocompatibility, photostability, and remarkable absorption cross‐sections (ɛ), the latter of which can offset the reduced Φ of the organic material to afford brilliant emission (ɛ × Φ). Here, a structurally simple, scalable furan‐flanked diketopyrrolopyrrole material (PDFT) with peak emission at 950 nm is investigated, and the role of backbone architecture, molecular weight, and particle size on NIR‐II emission brightness are explored. PDFT CPNs features extraordinary brightness and photostability in solution and in vivo, outperforming indocyanine green and many contemporary NIR‐II emitters. Through rational structural modifications across multiple length scales, the NIR‐II brightness is enhanced >5000× beyond alternative small molecules, featuring a minimum detectable dose of 0.65 n m in vivo. This performance, combined with synthetic accessibility and scalability, positions PDFT as a promising material for NIR‐II bionanotechnologies.


  • Effects of Volatile Anesthetics versus Ketamine on Blood-Brain Barrier Permeability via Lipid-Mediated Alterations of Endothelial Cell Membranes

    by Behnam Noorani, Ekram Ahmed Chowdhury, Faleh Alqahtani, Yeseul Ahn, Ehsan Nozohouri, Sumaih Zoubi, Dhavalkumar Patel, Laurence Wood, Juyang Huang, Muhammad Bilal Siddique, et al.

    The purpose of this study was to investigate the effects of volatile anesthetic agents isoflurane and sevoflurane, at clinically relevant concentrations, on the fluidity of lipid membranes and permeability of the blood-brain barrier (BBB). We analyzed the in vitro effects of isoflurane or ketamine using erythrocyte ghosts (sodium fluorescein permeability) monolayers of brain microvascular endothelial cells ([13C]sucrose and fluorescein permeability), or liposomes (fluorescence anisotropy). Additionally, we determined the effects of 30-min exposure of mice to isoflurane on the brain tight junction proteins. Finally, we investigated in vivo brain uptake of [13C]mannitol and [13C]sucrose after IV administration in mice under anesthesia with isoflurane, sevoflurane, or ketamine/xylazine in addition to the awake condition. Isoflurane at 1- and 5-mM concentrations increased fluorescein efflux from the erythrocyte ghosts in a concentration-dependent manner. Similarly, in endothelial cell monolayers exposed to 3% (v/v) isoflurane, permeability coefficients rose by about 25% for fluorescein and 40% for [13C]sucrose, while transendothelial resistance and cell viability remained unaffected. Whereas isoflurane caused a significant decrease in liposomes anisotropy values, ketamine/xylazine did not show any effects. Brain uptake clearance (apparent Kin) of the passive permeability markers in vivo in mice approximately doubled under isoflurane or sevoflurane anesthesia, compared to either ketamine/xylazine anesthesia or the awake condition. In vivo exposure of mice to isoflurane did not change any of the brain tight junction proteins. Our data support membrane permeabilization rather than loosening of intercellular tight junctions as an underlying mechanism for increased permeability of the endothelial cell monolayers and the BBB in vivo. Significance Statement The BBB controls the entry of endogenous substances and xenobiotics from the circulation into the central nervous system. Volatile anesthetic agents like isoflurane alter the lipid structure of cell membranes, transiently facilitating the brain uptake of otherwise poorly permeable, hydrophilic small molecules. Clinical implications may arise when potentially neurotoxic drugs gain enhanced access to the CNS under inhalational anesthetics.